The FASEB Journal, Vol 9, 411-418, Copyright © 1995 by The Federation of American Societies for Experimental Biology

RESEARCH COMMUNICATIONS

Captopril increases skin microvascular blood flow secondary to bradykinin, nitric oxide, and prostaglandins

JB Warren and RK Loi
Department of Applied Pharmacology, National Heart and Lung Institute, London, United Kingdom.

Angiotensin converting enzyme inhibitors (ACEIs) are a cornerstone of treatment of hypertension and heart failure yet their mechanism of action is still debated. This study was designed to test whether the ACEI captopril increases skin microvascular blood flow by a bradykinin- dependent mechanism. Local changes in microvascular blood flow were measured in the skin of rabbits and of human volunteers using a laser Doppler flow probe. Captopril injected intradermally increased skin blood flow over the dose range of 10(-12)-10(-8) mol site in rabbits and humans. In both species the response was abolished by coinjecting either a nitric oxide synthase (NOS) inhibitor or a cyclooxygenase inhibitor. Intradermal bradykinin also increased rabbit skin microvascular blood flow; at 10(-11) mol site it increased mean +/- SE basal blood flow by 88 +/- 12%. The responses to bradykinin or captopril were abolished by coinjecting a bradykinin antagonist, a specific bradykinin B2 receptor antagonist, or inhibitors of NOS or cyclooxygenase. Injecting a specific angiotensin II receptor antagonist at a dose that antagonized the constrictor effects of exogenous angiotensin II did not cause a significant increase in rabbit skin blood flow. This suggests that endogenous angiotensin II does not influence microvascular blood flow in this model. The results indicate that captopril increases skin microvascular blood flow in rabbits and humans secondary to an increase in endogenous tissue bradykinin; this stimulates B2 receptors with subsequent release of prostaglandins and nitric oxide. ACEIs may increase microvascular perfusion by a bradykinin-dependent mechanism.

This article has been cited by other articles:

				V. F. Panoulas, G. S. Metsios, A. V. Pace, H. John, G. J. Treharne, M. J. Banks, and G. D. Kitas Hypertension in rheumatoid arthritis Rheumatology, May 29, 2008; (2008) ken159v2. [Abstract] [Full Text] [PDF]

				N. Toda, K. Ayajiki, and T. Okamura Interaction of Endothelial Nitric Oxide and Angiotensin in the Circulation Pharmacol. Rev., March 1, 2007; 59(1): 54 - 87. [Abstract] [Full Text] [PDF]

				S. Golay, C. Haeberli, A. Delachaux, L. Liaudet, P. Kucera, B. Waeber, and F. Feihl Local heating of human skin causes hyperemia without mediation by muscarinic cholinergic receptors or prostanoids J Appl Physiol, November 1, 2004; 97(5): 1781 - 1786. [Abstract] [Full Text] [PDF]

				I. Isordia-Salas, R. A. Pixley, H. Parekh, S. P. Kunapuli, F. Li, A. Stadnicki, Y. Lin, R. B. Sartor, and R. W. Colman The mutation Ser511Asn leads to N-glycosylation and increases the cleavage of high molecular weight kininogen in rats genetically susceptible to inflammation Blood, October 15, 2003; 102(8): 2835 - 2842. [Abstract] [Full Text] [PDF]

				K. Moridaira, J. Morrissey, M. Fitzgerald, G. Guo, R. McCracken, T. Tolley, and S. Klahr ACE inhibition increases expression of the ETB receptor in kidneys of mice with unilateral obstruction Am J Physiol Renal Physiol, January 1, 2003; 284(1): F209 - F217. [Abstract] [Full Text] [PDF]

				D. L. Kellogg Jr., Y. Liu, K. McAllister, C. Friel, and P. E. Pergola Bradykinin does not mediate cutaneous active vasodilation during heat stress in humans J Appl Physiol, October 1, 2002; 93(4): 1215 - 1221. [Abstract] [Full Text] [PDF]

				G. Sukau, M. Pollok, C. A. Baldamus, and T. A. Marsen Enalapril and Losartan Augment Endogenous Nitric Oxide Release in Takayasu's Arteritis: A Case Report Angiology, January 1, 2000; 51(1): 69 - 75. [Abstract] [PDF]

				J.-E. Fabre, A. Rivard, M. Magner, M. Silver, and J. M. Isner Tissue Inhibition of Angiotensin-Converting Enzyme Activity Stimulates Angiogenesis In Vivo Circulation, June 15, 1999; 99(23): 3043 - 3049. [Abstract] [Full Text] [PDF]

				W. Wang Cardiac sympathetic afferent stimulation by bradykinin in heart failure: role of NO and prostaglandins Am J Physiol Heart Circ Physiol, September 1, 1998; 275(3): H783 - H788. [Abstract] [Full Text] [PDF]